Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 1.30

Amneal Pharmaceuticals, Inc. Interest Coverage Ratio is 1.30 for the Trailing 12 Months (TTM) ending March 31, 2025, a -8.00% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 1.41, a -985.31% change year over year.
  • Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was -0.16, a -111.42% change year over year.
  • Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 1.40, a 56.10% change year over year.
  • Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 0.90, a 229.84% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)